Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications

Area of Science:

• Oncology
• Molecular Biology
• Angiogenesis Research

Background:

• Cancer development relies on new blood vessel formation (neovascularization).
• Vascular Endothelial Growth Factor (VEGF) is a key regulator of this process.
• VEGF promotes endothelial cell growth, survival, vascular permeability, and progenitor cell recruitment.

Purpose of the Study:

• To review the clinical implications of VEGF in cancer.
• To highlight VEGF's role as a prognostic and predictive marker.
• To discuss the therapeutic potential of targeting VEGF in oncology.

Main Methods:

• Review of existing literature on VEGF in cancer.
• Analysis of clinical observations linking VEGF status to tumor progression and prognosis.
• Examination of preliminary anti-VEGF treatment data.

Main Results:

• VEGF status correlates with neovascularization extent and prognosis in solid tumors.
• VEGF status predicts resistance to radiotherapy, chemotherapy, and endocrine therapy.
• Anti-VEGF therapies show potential for cancer progression suppression with low toxicity.

Conclusions:

• VEGF is a critical factor in tumor angiogenesis.
• VEGF status holds significant prognostic and predictive value in various cancers.
• Inhibiting VEGF activity represents a promising therapeutic strategy in oncology.